Bueter Marco, Thalheimer Andreas, Wierlemann Alexander, Fein Martin
Department of Surgery I, Julius-Maximilians-University of Wuerzburg, Oberduerrbacher Strasse 6, 97080 Wuerzburg, Germany.
Surg Endosc. 2009 Feb;23(2):334-40. doi: 10.1007/s00464-008-9926-8. Epub 2008 Apr 29.
Laparoscopic gastric banding (LAGB) is the most popular surgical procedure for morbid obesity in Europe. Long-term complications like slippage of the band or pouch dilatation are well known and lead to reoperations in a substantial number of patients. In this study, results and follow-ups of patients with reoperations after gastric banding were analyzed.
Between May 1997 and June 2006, 172 patients were treated with LAGB for morbid obesity. 41 of these patients underwent one or more band-related reoperations (female symbol = 32, male symbol = 9). Causes for and type of reoperation were analyzed. Weight loss and comorbidities were compared for different types of reoperations.
There were no deaths following the reoperations. Band replacement (n = 18), band repositioning (n = 7), conversion to sleeve gastrectomy (SG, n = 2) and Roux-en-Y gastric bypass (RYGBP, n = 2) or band removal without any further substitution (n = 12) were performed as first reoperation. Seven patients had a second reoperation: RYGBP (n = 3), SG (n = 1), or band removal (n = 3). Median follow-up since reoperation was 56 months (range 7-113). Excess weight loss (EBWL%) of patients was 59.4% after RYGBP (n = 5), 45.1% after re-banding (n = 18), and 33.4% after SG (n = 2). Comorbidities were further reduced or even resolved after reoperation. Patients whose band was removed without subsequent bariatric procedures lost significantly less weight (n = 13, EBWL% 23.4) than patients with band replacement (n = 18, EBWL% 46.4, p = 0.04).
Laparoscopic reoperation after LAGB is safe and feasible. Reoperation leads to further decrease of BMI and obesity-related comorbidities. Band replacement is a good option for patients with good weight loss after initial LAGB. Alternative procedures, preferably RYGBP, are required for cases of band failure. Overall, RYGBP appears to be the most effective option to induce further weight loss.
腹腔镜胃束带术(LAGB)是欧洲治疗病态肥胖最常用的外科手术。诸如束带滑脱或胃囊扩张等长期并发症广为人知,并且导致大量患者需要再次手术。在本研究中,分析了胃束带术后再次手术患者的结果及随访情况。
1997年5月至2006年6月期间,172例患者接受了LAGB治疗病态肥胖。其中41例患者接受了一次或多次与束带相关的再次手术(女性 = 32例,男性 = 9例)。分析了再次手术的原因及类型。比较了不同类型再次手术的体重减轻情况及合并症。
再次手术后无死亡病例。首次再次手术包括束带更换(n = 18)、束带重新定位(n = 7)、转为袖状胃切除术(SG,n = 2)和Roux-en-Y胃旁路术(RYGBP,n = 2)或束带移除且未进行任何进一步替代(n = 12)。7例患者进行了第二次再次手术:RYGBP(n = 3)、SG(n = 1)或束带移除(n = 3)。再次手术后的中位随访时间为56个月(范围7 - 113个月)。RYGBP术后患者的超重体重减轻百分比(EBWL%)为59.4%(n = 5),再次束带术后为45.1%(n = 18),SG术后为33.4%(n = 2)。再次手术后合并症进一步减轻甚至得到解决。束带移除后未进行后续减肥手术的患者体重减轻明显少于束带更换患者(n = 13,EBWL% 23.4)(n = 18, EBWL% 46.4,p = 0.04)。
LAGB术后腹腔镜再次手术安全可行。再次手术导致BMI及肥胖相关合并症进一步降低。对于初次LAGB术后体重减轻良好的患者,束带更换是一个不错的选择。对于束带失败的病例,需要采用替代手术,最好是RYGBP。总体而言,RYGBP似乎是促使进一步体重减轻的最有效选择。